You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1698 Results
Guidelines and Advice
Status: In-Review
ID: 17-9
Dec 2014
Guidelines and Advice
Status: Current
ID: GL 16-3
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
ID: GL 9-11
Oct 2024
Guidelines and Advice
Status: Current
ID: 26-3
Version: 2
Feb 2024
Guidelines and Advice
Status: In-Review
ID: 16-4
May 2015
Guidelines and Advice
Status: Current
ID: GL 4-1
Version: 2
Jan 2021
Guidelines and Advice
Status: Archived
ID: 15-10
Apr 2013
Guidelines and Advice
Status: Current
ID: MOTAC-6
Version: 2
Sep 2020
Guidelines and Advice
Status: In-Review
ID: 27-3
Mar 2016
Guidelines and Advice
Status: Current
ID: GL 27-2
Version: 2
Feb 2021
Guidelines and Advice
Status: Current
ID: GL SCT-8
Oct 2017
Regimen
Cancer Type:
Sarcoma, 
Giant Cell Tumour
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
denosumab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2024

Pages